- Home
- SELF vs PEPG Comparison
SELF vs PEPG Comparison
Compare SELF & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- PEPG
- Stock Information
- Founded
- SELF 1983
- PEPG 2018
- Country
- SELF United States
- PEPG United States
- Employees
- SELF N/A
- PEPG N/A
- Industry
- SELF Real Estate Investment Trusts
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- SELF Real Estate
- PEPG Health Care
- Exchange
- SELF Nasdaq
- PEPG Nasdaq
- Market Cap
- SELF 58.8M
- PEPG 64.2M
- IPO Year
- SELF N/A
- PEPG 2022
- Fundamental
- Price
- SELF $5.13
- PEPG $1.37
- Analyst Decision
- SELF
- PEPG Buy
- Analyst Count
- SELF 0
- PEPG 3
- Target Price
- SELF N/A
- PEPG $14.67
- AVG Volume (30 Days)
- SELF 15.9K
- PEPG 482.2K
- Earning Date
- SELF 03-25-2025
- PEPG 03-05-2025
- Dividend Yield
- SELF 5.66%
- PEPG N/A
- EPS Growth
- SELF 39.82
- PEPG N/A
- EPS
- SELF 0.28
- PEPG N/A
- Revenue
- SELF $12,319,724.00
- PEPG N/A
- Revenue This Year
- SELF N/A
- PEPG N/A
- Revenue Next Year
- SELF N/A
- PEPG N/A
- P/E Ratio
- SELF $18.35
- PEPG N/A
- Revenue Growth
- SELF 0.38
- PEPG N/A
- 52 Week Low
- SELF $4.01
- PEPG $1.16
- 52 Week High
- SELF $5.85
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- SELF 46.76
- PEPG 31.82
- Support Level
- SELF $5.10
- PEPG $1.16
- Resistance Level
- SELF $5.25
- PEPG $1.60
- Average True Range (ATR)
- SELF 0.09
- PEPG 0.14
- MACD
- SELF -0.00
- PEPG 0.11
- Stochastic Oscillator
- SELF 16.67
- PEPG 48.28
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.